Publications by authors named "H Safar"

The human respiratory syncytial virus (RSV) is a significant health concern, particularly for infants, young children, and the elderly. This virus is known to evolve continuously due to environmental factors and herd immunity. In light of this, our study aimed to analyze the genetic variability of the G protein in RSV-A and RSV-B genotypes in Kuwait from 2020 to 2022.

View Article and Find Full Text PDF
Article Synopsis
  • * The World Health Organization's "One-Health" approach emphasizes the need to assess ARGs in the environment to combat AMR's development and spread.
  • * New research highlights the role of aerosols from wastewater treatment plants, hospitals, and livestock facilities in disseminating AMR, signaling a need for ongoing monitoring and health advisories for affected communities.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the genetic diversity of the human respiratory syncytial virus (RSV) in Kuwait, particularly among patients with acute respiratory tract infections from 2020 to 2022.
  • Researchers collected over 7,000 samples and sequenced the entire genomes of 84 RSV-positive samples, finding a higher prevalence of RSV group A compared to group B.
  • The study identified new lineages of RSV circulating in Kuwait, significant genetic variability, and important molecular markers associated with different genotypes, marking the first comprehensive genomic analysis of RSV in the region.
View Article and Find Full Text PDF

Background: Eukaryotes' whole-genome sequencing is crucial for species identification, gene detection, and protein annotation. Oxford Nanopore Technology (ONT) is an affordable and rapid platform for sequencing eukaryotes; however, the relatively higher error rates require computational and bioinformatic efforts to produce more accurate genome assemblies. Here, we evaluated the effect of read correction tools on eukaryote genome completeness, gene detection and protein annotation.

View Article and Find Full Text PDF

Human cytomegalovirus (CMV) continues to be a source of severe complications in immunologically immature and immunocompromised hosts. Effective CMV vaccines that help diminish CMV disease in transplant patients and avoid congenital infection are essential. Though the exact roles of defense mechanisms are unidentified, virus-specific antibodies and cytokine responses are known to be involved in controlling CMV infections.

View Article and Find Full Text PDF